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Abstract
Background: The purine salvage enzyme inosine 5'-monophosphate (IMP)-specific 5'-nucleotidase
catalyzes degradation of IMP to inosine. Although this enzymatic activity has been purified and
characterized in Saccharomyces cerevisiae, the gene encoding IMP 5'-nucleotidase had not been
identified.
Results: Mass spectrometry analysis of several peptides of this enzyme purified from yeast allowed
identification of the corresponding gene as YOR155c, an open reading frame of unknown function,
renamed ISN1. The deduced Isn1p sequence was clearly not homologous to 5'-nucleotidases from
other species. However, significant similarities to Isn1p were found in proteins of unknown
function from Neurospora crassa, Plasmodium falciparum and several yeast species. Knock-out of
ISN1 resulted in the total loss of IMP-specific 5'-nucleotidase activity, thus confirming that the ISN1
gene indeed encodes the enzymatic activity purified from yeast. In vivo studies revealed that, when
IMP is overproduced through constitutive activation of the IMP de novo synthesis pathway, ISN1 is
required for excretion of inosine and hypoxanthine in the medium.
Conclusion: We have identified a new yeast gene, ISN1 (YOR155c), as encoding IMP-specific 5'-
nucleotidase activity. The ISN1 gene defines a new type of 5'-nucleotidase which was demonstrated
to be functional in vivo.
Background
Purine salvage pathway allows interconversion of bases,
nucleosides and nucleotides. Importance of this pathway
in humans has been clearly established since several de-
fects in purine salvage enzymes have been associated to
pathologies such as mental retardation and severe immu-
nodeficiencies [1,2]. In yeast, mutations in several purine
salvage genes lead to deregulation of AMP biosynthesis
[3] and purine excretion. Taking advantage of complete
genome sequencing of Saccharomyces cerevisiae we were
able to identify several new purine salvage genes such as
adenosine kinase or purine nucleoside phosphorylase
[4,5] which are highly homologous to their mammalian
counterpart. Strikingly, no 5'-nucleotidase encoding gene
could be inferred from comparison of the completely se-
quenced yeast genome with 5'-nucleotidase genes from
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other species, although several lines of evidence argued
for the presence of 5'-nucleotidase in yeast. First, an IMP-
specific 5'-nucleotidase activity was detected and purified
from yeast [6]. Second, deregulation of IMP biosynthesis
resulted in increased production of IMP which was excret-
ed in the medium as a mix of inosine and hypoxanthine
[7], thus establishing that, in vivo, IMP could be efficiently
degraded to inosine in yeast.
In this paper, we report the identification of the yeast IMP-
specific 5'-Nucleotidase (ISN1) gene encoding a new type
of 5'-nucleotidase.
Results and discussion
IMP-specific 5'-nucleotidase corresponds to Yor155p
The IMP-specific 5'-nucleotidase purified as described pre-
viously [6] was submitted to EndoLysC proteolytic treat-
ment. The MALDI-MS spectrum of the peptide mixture
generated by EndoLysC proteolysis revealed 9 major
peaks in the m/z 1000–3000 range, that were used for
data base search (Table 1). YOR155c, an open reading
frame of unknown function (Swissprot/TrEMBL accession
number Q99312) was identified with 8 peptide matches
within an 0.1 Da error range (MS-Fit search, see Experi-
mental). Identification was further confirmed by an inde-
pendent data base search (MS-Tag) with PSD fragment
ions obtained from a precursor ion measured at 1845.91
Da (calculated mass 1845.98 Da, matching the 318–334
stretch of the protein, Table 1). The unmatched peptide
ion, measured at 1479.73 Da, was submitted to PSD anal-
ysis (Figure 1) and assigned to the N-terminal peptide SS-
RYRVEYHLK having undergone methionine excision and
bearing an acetyl blocking group (calculated mass of the
modified peptide 1479.77 Da). Based on mass spectrom-
etry identification and further results presented below,
YOR155c was renamed ISN1 (IMP-specific 5'-Nucleoti-
dase).
ISN1 encodes an atypical 5'-nucleotidase
Search for conserved motif in S. cerevisiae Isn1p revealed a
typical leucine zipper sequence (Fig. 2) that could be in-
volved in multimerization of the protein which was first
isolated as a tetramer [6]. Indeed, Yor155p was found to
interact with itself in a systematic two hybrid analysis
[13]. The sequence analysis of the ISN1 gene product re-
vealed that it does not have significant homologies with
any 5'-nucleotidase from other organisms neither
eucaryotes or prokaryotes nor to the S. cerevisiae pyrimi-
Figure 1
Partial spectrum of PSD fragment ions obtained from m/z 1479.76 precursor ion. Masses of N-terminal ion series 
of the b and a type [12] are in agreement with the modified sequence Acetyl-SSRYRVEYHK. His and Tyr immonium ions, as 
well as C-terminal ions (y type) confirm the sequence of the modified peptide.
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dine 5'-nucleotidase encoded by the SDT1 gene [14]. The
only significant similarities were found with proteins of
unknown function derived from complete genome se-
quencing of Schizosaccharomyces pombe, Neurospora crassa
and Plasmodium falciparum (Fig. 2) as well as partially se-
quenced open reading frames of Saccharomyces bayanus,
Saccharomyces exiguus, Kluyveromyces lactis, Pichia angusta,
Pichia sorbitophila (Table 2).
Table 1: Assignment of major peptide ions observed in the MALDI-ToF mass spectrum of the EndoLysC protein digest Mass values are 
monoisotopic for [M+H]+ ions. For the N-terminal peptide, the calculated mass takes into account a modification by methionine 
excision (- 131.04 Da) and acylation (+ 42.01 Da), the theoretical mass of the unmodified peptide being 1568.80 Da.
Measured mass (Da) Calculated mass (Da) Stretch location Sequence ions identified by PSD analysis
1051.48 1051.51 17–24
1076.49 1076.53 282–290
1201.67 1201.64 273–281
1479.76 1479.77 2–12 y2-y4, b2-b8, a5-a8, H and Y immonium ions
1538.92 1538.94 305–317
1559.78 1559.80 13–24
1732.96 1732.98 291–304
1792.97 1792.98 224–240
1845.99 1845.98 318–334 y2-y4, b2-b5, a4-a7, R,V and Y immonium ions
Figure 2
Sequence comparison of Isn1p and putative proteins from various species. The amino acid sequence deduced from 
the nucleotide sequence of the YOR155c ORF (Isn1p) from S. cerevisiae (Sc) was compared with putative proteins derived from 
complete genome sequencing of Plasmidium falciparum (Pf) Schizosaccharomyces pombe (Sp) and Neurospora crassa (Nc). Acces-
sion numbers are presented in Table 2. Residues conserved in all four proteins are shown by asterisks. Dashes indicate the 
gaps created for alignment. The putative leucine zipper sequence in Isn1p is highlighted in grey.
Sc ---MSSRYRVEYHLKSHRKDEFIDWVKGLLASPFVLHAVSH-----EGDYN-DDLATT-QRVRSQYADIFK--DIEGLIKDKIEFDSRNMSQDEIEDGAS 
Pf MKNLDINTFDNIEDIPLGSSEQDPYDFFTLSDRNVMNSDMKKNIVQWNSRYSYNQLKNKDSLIMFLVEIFRSLFVSNCIDKNIDN-----VLLSIEEMFI 
Sp ---MASRYRVEYALKQHRKDDFIEWIKGLLSVPFVLQAG-------TPSQKLVTREKE-QETLERYAVILR--DVEKLIEAHIQI---------VSEGGS 
Nc ---MASLPPSCWMFLPARLAESTEWIKALLAVPFVLYSQPHG-VLEDPDRSVDTLSQTREEAHRRYSEIFR--DIEAMIDDHIAH------QNDAENPFP 
                                *    *                                 *         *   *
Sc SQSLNILGQSRLNLLVPSIGTFFTELPLEQAFLWEDSQRAISARRMVAPSFNDIRHILNTAQIFHFKKQENLHNGKVLRLVTFDGDVTLYEDGGSLVYTN 
Pf DHYYN-PQHSRLKYLIDDVGIFFTKLPITKAFHTYNKKYRITKRLYAPPTFNEVRHILNLAQILSLEEG--------LDLLTFDADETLYPDGHDFN--D 
Sp --------YSQLKMLVPSITIFWTPLPLVKAMYALEPKLCLAKRSFVAPSFNDVRAILGGAQLNYLADNG-------LDMVSFDGDVTLYEDGQPLLPDN 
Nc ---------SKLKLLVPSIGPFFTRLPLEAAFKFQDNKRYISSRRFVSPSFNDIRLILNSAQIMAVTTYG------TLQLATFDGDVTLYDDGQSLEPTS 
            * *  *      * * **   *            *    * **  * **  **               *    ** * *** **
Sc PVIPYILKLLRCGINVGIVTAAGYD--EAGTYENRLKGLIVALHDSTDIPVSQKQNLTIMGGESSYLFRYYEDPEEDNFGFRQIDKEEWLLPRMKAWSLE 
Pf EVLASYISCLLKKMNIAIVTAASYNN-DAEKYQKRLENLLKYFSKH-NIKDGSYKNFYVMGGESNYLFKCNEEAT-----LYSVPENEWR-HYKKFVDYD 
Sp PVISRLIQLLSRGIYVIILTAAGYPSRTGQEYTDRFSGLLQAIEDS-DLKDGQKRKLHVLGGESNYLFAYDP-----LHGLQWVDADSWMLPVMKTWPHD 
Nc PVIPRLLDLLRKNVKIGIVTAAGYT--TADRYYSRLHGLLDAMANSADLTPSQKQSLVVMGGEANYLFEFDSSSP---HLLAPVPRQHWLTPEMAAWNEQ 
    *       *       * *** *       *  *   *                     ***  ***                    *
Sc DVEKTLDFAERTLNRLRKRLNLPSEISIIRKVRAVGIVPGER-YDEASKRQVPVKLDREQLEEIVLTLQNTLES--FAPSRRIQFSCFDGGSDVWCDIGG 
Pf TVQEILNISEKCLEKVIKDFGLC--AQIQRKEKSIGLVPNKIPSLNIKNEQKNYMIKYEVLEEAVIRIKKEIIK----NKITAPYCAFNGGQDLWVDVGN 
Sp EILEILDTAEETLRSCIQGLNID--AKIVRKERSVGFVP------SLG-----QKLRREQLEEAVLETQATLQI----RNFSVPFTAFNGGNDIWCDIGD 
Nc DIAQLLDVAEAALRDCIKTLNLP--ATLMRKDRAVGIIP-------VSP---EIRIPRESLEETVLLVQKILELSTVGRSRRVPFCAFNGGRDVFVDIGD 
        *   *  *                **    *  *                   * *** *                      * ** *   * *
Sc KDLGVRSLQQFYN----PESPIQPSETLHVGDQFAPVGSANDFKARLAG-----CTLWIASPQETVNYLHRLLETD------------- 
Pf KAEGLLILQKLLK--------IQKKKCCHIGDQFLHSG--NDFPTRLDLYIFCSLTLWVSNPQETKACLKSIMHLNIKSFIPEVLYENQ 
Sp KKLGVLCLQHFFN-------ISHPSRCLHVGDQFLSAG-NNDYKARAAA-----TTVWVSSPHETIEFLDYYFSFLKK----------- 
Nc KSWGVTVCQRWFSQKEGPHGVIKGENTLHVGDQFLSAG-ANDFRARSVG-----TTAWIASPVETVELLDELAELMGKKMS-------- 
   *  *    *                   * ****   *  **   *         * *   * **   *BMC Biochemistry 2003, 4 http://www.biomedcentral.com/1471-2091/4/4
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It therefore seems that IMP degradation in these species
occurs through an atypical enzyme. Strikingly, the other
yeast IMP metabolizing enzymes such as IMP dehydroge-
nase and adenylosuccinate synthetase are highly similar
to bacterial and mammalian enzymes [15,16]. Interest-
ingly, hypoxanthine-guanine phosphoribosyl transferase
from yeast is also poorly conserved [3] except among yeast
species, while other purine salvage enzymes such as ade-
nosine kinase or purine nucleoside phosphorylase are
highly conserved from yeast to mammals [4,5]. It there-
fore clearly appears that some purine salvage enzymes are
derived from a common ancestor with mammalian en-
zymes, while others have evolved differently in yeast and
mammals. This intriguing observation could be useful for
future development of specific antifungal drugs.
Activities of 5'-nucleotidase and non-specific phosphatase 
in yeast cell extracts
To evaluate the role of Isn1p in IMP-specific 5'-nucleoti-
dase activity, the enzymatic activity was measured in ex-
tracts from a wild-type strain and an isogenic isn1 knock-
out mutant. IMP-hydrolyzing activity in the extract from
wild-type strain was ca 17 × 10-3 units/mg protein, while
the activity in the extract from the mutant strain was virtu-
ally undetectable (Fig. 3). The hydrolyzing-activities with
phenylphosphate, which is not a substrate for IMP 5'-nu-
cleotidase [6], were ca 12 × 10-3 units/mg for the knock-
out strain and ca 11 × 10-3 units/mg for the wild-type
strain (Fig. 3.). Similar results were obtained in experi-
ments assessing phosphomonoesterase activities with var-
ious phosphomonoesters as substrates (Table 3). IMP-
hydrolyzing activity in the crude extracts from the isn1
knock-out strain was lower than 3% of that in the wild-
type strain. Activities with each tested phosphomonoester
other than IMP were almost equal in both strains.
These results clearly show that in the absence of the ISN1
gene, the IMP-specific 5'-nucleotidase activity is absent.
Together with identification of the purified protein by
mass spectrometry, this result clearly establishes that ISN1
encodes yeast IMP-specific 5'-nucleotidase.
Role of Isn1p in vivo
Because of its high substrate specificity, Isn1p most prob-
ably regulates intracellular IMP amounts. To test the role
of Isn1p in vivo, we took advantage of mutants in the
ADE4 gene increasing the flux in the IMP biosynthesis
pathway [7]. In these mutants, hypoxanthine and inosine
are excreted in the growth medium, most probably as a
Table 2: Sequence comparison between Isn1p and similar proteins from various species.
Species Identity % Length of alignment Accession number
Plasmodium falciparum 33 349 AAN36150
Neurospora crassa 44 440 EAA34993
Schizosaccharomyces pombe 44 448 CAB10798
Pichia angusta 50 328 (a)
Pichia sorbitophila 51 251 (a)
Kluyveromyces lactis 66 112 (a)
Saccharomyces exiguus 83 24 (a)
Saccharomyces bayanus 94 196 (a)
Saccharomyces cerevisiae 100 450 CAA99361
(a) genolevure program http://cbi.labri.u-bordeaux.fr/Genolevures/
Figure 3
IMP 5'-nucleotidase activity is undetectable in an isn1 
mutant. Time course of hydrolysis of IMP (circles) or phe-
nylphosphate (squares) in crude extracts from the isn1 
knock-out strain (A) or wild-type strain (B). Reaction mix-
tures contained 10 mM IMP or phenylphosphate, 25 mM 
MgCl2, and 0.1% BSA in 100 mM imidazole/HCl (pH 6.5). The 
amounts of protein in the cell extracts used in these experi-
ments were 270 µg for both isn1 knock-out and wild type 
strains.
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result of degradation of overproduced IMP [7]. We there-
fore used such an IMP overproducing mutant to assay
whether IMP degradation would be affected in an isn1
mutant strain. A plasmid (P2047) overexpressing a domi-
nant mutant form of ADE4 leading to purine excretion [7]
was transformed in wild-type and isn1 yeast strains and
purine excretion was assayed. Indeed, crossfeeding exper-
iments revealed that hypoxanthine excretion (allowing
growth of a halo of hypoxanthine auxotrophic cells) was
much lower in an isn1 mutant strain (Fig. 4A). Analysis of
the purine compounds excreted in the growth medium by
isogenic wild-type and isn1 mutant strains revealed very
different excretion patterns (Fig. 4B). While the P2047-
transformed wild-type strain excreted inosine, hypoxan-
thine and also a significant amount of IMP (Fig. 4B)
(compared to the non-excreting control, not shown), in
the P2047-transformed mutant strain, IMP only was still
efficiently excreted, whereas neither inosine nor hypoxan-
thine were detected in the growth medium (Fig. 4B). This
result clearly shows that Isn1p plays a critical role in IMP
degradation in vivo.
Why should yeast have a specific IMP 5'-nucleotidase?
One possibility is that Isn1p could be involved in scaveng-
ing IMP toxic derivatives or analogs. Our attempts to doc-
ument such an effect were unsuccessful : the isn1 knock-
out mutant, grown in the presence of several purine ana-
logs (8-azaadenine, 6-chloropurine, 8-azaguanine, 6-mer-
captopurine, 2,6-diaminopurine...), did not show any
growth alteration compared to the isogenic wild-type
strain (data not shown). Alternatively, Isn1p could play
some role in DNA repair. Indeed, transcriptome analysis
revealed that ISN1  transcription increased three folds
when cells were treated with methyl methanesulfonate, a
DNA damaging agent [17], and furthermore, Isn1p co-pu-
rified with Mlh1p [18], a protein involved in mismatch re-
pair [19]. It is therefore tempting to propose that Isn1p
could for example be involved in removing dIMP residues
resulting from deamination of dAMP. However, while the
mutagenic effect of dIMP has been documented [20], this
deoxynucleotide is a poor substrate for Isn1p in vitro [6].
Whatever its involvement in DNA damage response, it is
clear that Isn1p activity is present in normally growing
cells [6]. This result together with the extreme substrate
specificity of Isn1p argues for a physiological role of Isn1p
in IMP metabolism. Deregulation of IMP production
leads to excretion of inosine and hypoxanthine [7], sug-
gesting that IMP should not normally accumulate, and we
have shown (Fig. 4) that Isn1p is clearly required for this
process. However, overproduction of IMP in an isn1 mu-
tant strain did not result in any obvious growth pheno-
Table 3: Specific activities in cell extracts with various 
phosphomonoesters Each reaction mixture contained 10 mM 
substrate, 25 mM MgCl2, 0.1% BSA in 100 mM imidazole/HCl (pH 
6.5)
Substrates Activity (unit × 103/mg protein)
Knock-out strain Wild-type strain
IMP 0.4 16.6
AMP 1.2 0.7
GMP 0.6 0.5
UMP 0.5 0.4
CMP 0.4 0.3
Phenylphosphate 11.7 11.2
1-Glycerophosphate 106.4 98.8
Figure 4
Excretion of purine compounds in the isn1 mutant 
strain. (A.) Purine excretion phenotype of the wild-type 
strain (BY4741) and the isn1 mutant strain transformed with 
the P2047 plasmid leading to IMP overproduction. Trans-
formed strains were spotted on a lawn of ade1 homozygous 
diploid cells plated on purine-free SD casa medium. Purine 
excretion was monitored after 3 days at 30°C. (B.) HPLC 
analysis of excreted purine compounds. Transformed strains 
as in (A) were grown in adenine- and uracil-free SD casa 
medium. Cells were then harvested and the medium was fil-
tered. Separation of purine compounds was achieved by 
HPLC and monitored by following absorbance at 260 nm. 
Specific peaks were identified as IMP, hypoxanthine and inos-
ine as described previously [7]. Arrows indicate the identified 
peaks with the following abbreviations: Hyp, hypoxanthine; 
Ino, inosine.
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type that would help us to further understand why yeast
cells have developped such an efficient way of degrading
IMP to inosine and hypoxanthine. Therefore, while the
enzymatic activity of Isn1p is well characterized, its phys-
iological role still remains unclear.
Conclusions
In this paper we report the identification of a new yeast
gene, ISN1 (YOR155c), as encoding IMP-specific 5'-nucle-
otidase activity. The ISN1 gene is the first member of a
new type of 5'-nucleotidase which appears conserved
among several species, from yeast to human malaria par-
asite. IMP-specific 5'-nucleotidase was found to be func-
tional in vivo although no clear physiological role could be
associated to Isn1p activity. Beside future physiological
work, identification of Isn1p will make possible structural
analysis required to further characterize this new type of
nucleotidase.
Methods
Purification of IMP-specific 5'-nucleotidase for amino acid 
sequence analyses
Yeast IMP-specific 5'-nucleotidase was purified as de-
scribed previously [6] and run on a 15% one-dimensional
SDS-PAGE [8]. Fixation and staining of proteins in the gel
were achieved by a two hours treatment with 0.003%
Amido Black in 45% ethanol, 10% acetic acid. The gel was
then washed several times with water to remove staining
excess and the band of interest was cut out and washed in
a large volume of water to remove acetic acid and ethanol.
In-Gel Protein Digestion
The purified 5'-nucleotidase protein band was washed
three times with 250 µl of 50% acetonitrile in 25 mM Tris-
HCl (pH 8.6) for 30 min at room temperature with gentle
agitation. The band was then sliced into small pieces (~1
× 1 × 0.75 mm) and partially dried under vacuum in a
SpeedVac concentrator. The gel was rehydrated in diges-
tion buffer (0.1 M Tris-HCl, pH 8.6, 10% acetonitrile)
containing 5 µg/mL of endoproteinase Lys-C (Roche Ap-
plied Science). Digestion was carried out for 16 h at 37°C
in a minimal volume allowing total immersion of gel
pieces and was stopped by addition of 1% (final concen-
tration) aqueous trifluoroacetic acid (TFA). Peptides re-
covered from the digestion mix and from the gel pieces
through three cycles of extraction with 60% acetonitrile,
0.1%TFA in water, were then pooled and concentrated in
a Speed-Vac. Finally, a micro-chromatographic separation
step of proteolytic digest was performed by means of a
C18 ZipTip (Millipore), using a 10 µl sample load. The
elution was achieved with 2 µl of 70% acetonitrile, 0.1%
TFA in water
Mass spectrometry
The matrix assisted laser desorption-ionization (MALDI)
mass spectrometer was a Reflex III (Bruker) instrument
equipped with a 337 nm laser source, ion gate and ion re-
flector suitable for Post Source Decay (PSD) experiments.
α-Cyano-4-hydroxy-cinnamic acid (Sigma) was used as a
matrix (saturated solution in 50% acetonitrile, 0.1%
aqueous TFA). The dried droplet method was used for
sample loading on stainless steel targets. External mass
calibration was achieved with a mixture of eight peptides
(angiotensin, bradikynin, bombesin, ACTH clips and
oxidized insulin B chain, all from Sigma) covering the m/
z 1000–3500 range. For PSD analysis, the reflector voltage
was stepped down in 10 to 12 steps, starting from 30 kV,
in order to collect fragment ions from the precursor down
to immonium ions. Data base search was effected by
means of the Protein Prospector MS-Fit ans MS-Tag search
engines http://falcon.ludwig.ucl.ac.uk, using a mass
tolerance of 0.2 Da for precursor ions, and 0.5 Da for PSD
fragment ions.
Yeast strains and media
Yeast strains used in this study were purchased from
Euroscarf.
BY4741: MATa ura3∆0 leu2∆0 met15∆0 his3∆1
Y02411:  MATa  ura3∆0 leu2∆0 met15∆0 his3∆
yor155c::KanMX4
SD is 0.17% nitrogen base, 2% glucose and 0.5% ammo-
nium sulfate. SD casa is SD supplemented with 0.2%
casamino acids (Difco).
Plasmids
The P2047 ADE4 mutant plasmid was constructed as fol-
lows : the mutant ADE4 coding sequence was amplified
from the BRA11-2 [7] genomic DNA using oligonucle-
otides 48 and 429.
48 : 5' CGCGGATCCAAATGTGTGGTATTTTAG 3'
429 : 5' AAACTGCAGTCAATAATCTGCACAATTATATAAT
C 3'
The resulting PCR fragment was digested with BamHI and
PstI and introduced in the pCM189 vector [9] digested
with BamHI and PstI. The resulting plasmid allows expres-
sion of the ADE4 mutant gene under control of a tetracy-
clin regulatable promoter.
Preparation of cell extracts for enzyme assay
Harvested yeast was suspended in ca 3 vol of Tris/HCl
buffer (pH 7.4) containing 1 mM EDTA and 10 mM 2-
mercaptoethanol (Buffer A). The cells were disrupted byBMC Biochemistry 2003, 4 http://www.biomedcentral.com/1471-2091/4/4
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vigorous shaking for 3 min with glass beads (ca 1 mm di-
ameter) in a Pyrex test tube. The resulting solution was
centrifuged at 100,000 g for 60 min. Supernatant was
thoroughly dialyzed against ca 200 vol of buffer A
overnight.
Enzyme assay
Phosphomonoesterases were assayed colorimetrically by
measuring inorganic phosphate (Pi) released from vari-
ous phosphomonoesters using the methods by Chen et al.
[10]. Assays were performed at 37°C. The reaction
mixture contained 100 mM imidazole/HCl buffer (pH
6.5), 25 mM MgCl2, 0.1% BSA, 10 mM phosphomo-
noester substrate and appropriate amount of cell extracts.
For IMP-specific 5'-nucleotidase assay IMP was used as a
substrate. For assay of non-specific phosphatases,
phenylphosphate or 1-glycerophosphate was used as a
substrate. One unit of the enzyme activity corresponds to
the release of 1 µmol of Pi/min from the substrate. Protein
concentration was determined by the method of Lowry et
al. [11] using crystalline BSA as a standard.
HPLC analysis of excreted purine compounds
Wild type and isn1 strains transformed with P2047 were
grown in adenine and uracil free SD casa medium. Cells
were then harvested and the medium was filtered on 0.22
µm filter units. Separation of purine compounds of the
medium was achieved by HPLC on a Supelcosil LC-18 5
µm reversed phase column using a step gradient set up
with A buffer (0.01 M KH2PO4) and B buffer (20% A
buffer – 80% methanol). The following proportions of A
and B buffers, respectively (indicated in parentheses) were
used at the indicated run time : 0 min (97/3), 13 min (89/
11), 17 min (75/25), 19 min (30/70) and 27 min (97/3)
and the flow rate was 1 ml/min. Excreted purine com-
pounds separation was monitored by following absorb-
ance at 260 nm at the column end and the different peaks
obtained were identified by comparison with the reten-
tion time of known standards.
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